摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲氧基-3-三氟甲基苯胺 | 393-15-7

中文名称
4-甲氧基-3-三氟甲基苯胺
中文别名
3-(三氟甲基)-4-甲氧基苯胺;5-氨基-2-甲氧基三氟甲苯;3-三氟甲基-4-甲氧基苯胺
英文名称
4-methoxy-3-(trifluoromethyl)aniline
英文别名
4-Methoxy-3-trifluoromethyl-phenylamine
4-甲氧基-3-三氟甲基苯胺化学式
CAS
393-15-7
化学式
C8H8F3NO
mdl
MFCD00043460
分子量
191.153
InChiKey
CQJCPOVTPNWVBW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    28 °C
  • 沸点:
    112 °C
  • 密度:
    1.280±0.06 g/cm3(Predicted)
  • 闪点:
    112°C/18mm

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 危险等级:
    TOXIC
  • 危险等级:
    6.1
  • 危险品标志:
    Xi,T
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R20/21/22
  • 海关编码:
    2922299090
  • WGK Germany:
    3
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P261,P280,P305+P351+P338,P311
  • 危险品运输编号:
    2811
  • 危险性描述:
    H302+H312,H315,H319,H331,H335

SDS

SDS:6d73871641cc6970b05e3542ce352ca3
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Methoxy-3-(trifluoromethyl)aniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H412: Harmful to aquatic life with long lasting effects
P273: Avoid release to the environment

Section 3. Composition/information on ingredients.
Ingredient name: 4-Methoxy-3-(trifluoromethyl)aniline
CAS number: 393-15-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H8F3NO
Molecular weight: 191.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (4-Methoxy-3-(trifluoromethyl)aniline)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-甲氧基-3-三氟甲基苯胺盐酸 、 sodium nitrite 、 sodium acetate 作用下, 以 为溶剂, 反应 0.75h, 生成
    参考文献:
    名称:
    Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
    摘要:
    用于治疗由P2X3和/或P2X2/3受体拮抗剂介导的呼吸系统和胃肠道疾病的方法,包括向有此需要的受试者施用有效量的式(I)化合物:或其药学上可接受的盐,其中D、X、Y、R1、R2、R3、R4、R5、R6、R7和R8如本文所定义。
    公开号:
    US20070049609A1
  • 作为产物:
    描述:
    2-甲氧基-5硝基三氟甲苯 在 palladium diacetate potassium fluoride 、 polymethylhydrosiloxane 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 以98%的产率得到4-甲氧基-3-三氟甲基苯胺
    参考文献:
    名称:
    一锅法将硝基化合物转化为胺、羟胺、酰胺、磺胺和氨基甲酸酯的钯催化硅烷/硅氧烷还原
    摘要:
    醋酸钯 (II)、氟化钾水溶液和聚甲基氢硅氧烷 (PMHS) 的组合有助于在室温下将芳香族硝基化合物还原为苯胺。这些反应往往快速(30 分钟)、高产,并且可以耐受一系列其他官能团。用三乙基硅烷代替 PMHS/KF 可以将脂肪族硝基化合物还原为相应的羟胺。根据底物的不同,这两种条件都可以将产物胺原位转化为酰胺、磺酰胺和氨基甲酸酯。
    DOI:
    10.1055/s-2006-950231
点击查看最新优质反应信息

文献信息

  • Application of the Intramolecular Diels–Alder Vinylarenе (IMDAV) Approach for the Synthesis of Thieno[2,3-f]isoindoles
    作者:Mykola D. Obushak、Fedor I. Zubkov、Maryana A. Nadirova、Yevhen-Oleh V. Laba、Vladimir P. Zaytsev、Julya S. Sokolova、Kuzma M. Pokazeev、Victoria A. Anokhina、Victor N. Khrustalev、Yuriy I. Horak、Roman Z. Lytvyn、Miłosz Siczek、Vasyl Kinzhybalo、Yan V. Zubavichus、Maxim L. Kuznetsov
    DOI:10.1055/s-0039-1690833
    日期:2020.8
    3-(Thien-2-yl)- and 3-(thien-3-yl)allylamines, readily accessible from the corresponding thienyl aldehydes, can interact with a broad range of anhydrides and α,β-unsaturated acids chlorides (maleic, сitraconic­, and phenyl maleic anhydrides, сrotonyl and сinnamyl chlorides, etc.) leading to the formation of a thieno[2,3-f]isoindole core. Usually, the reaction sequence involves three successive steps:
    很容易从相应的噻吩基醛中获得的3-(噻吩-2-基)-和3-(噻吩-3-基)烯丙胺可以与各种酸酐和α,β-不饱和酰马来酸顺丁烯二酸)相互作用,以及苯基马来酸酐,叔丁酰和肉桂酰氯等),导致形成噻吩并[2,3- f ]异吲哚核。通常,反应顺序包括三个连续的步骤:初始烯丙胺的氮原子的酰化,分子内Diels-Alder乙烯基芳烃(IMDAV)反应以及Diels-Alder加合物中二氢噻吩环的最终芳构化。彻底研究了该方法的范围和局限性。借助X射线分析表明,关键步骤IMDAV反应通过exo进行。-过渡态,引起目标杂环的单一非对映异构体的排他形成。在马来酸酐的情况下,该方法允许获得官能取代的噻吩并[2,3- f ]异吲哚羧酸,其对于进一步转化和随后的生物筛选是潜在有用的底物。
  • [EN] COMPLEMENT MODULATORS AND RELATED METHODS<br/>[FR] MODULATEURS DU COMPLÉMENT ET PROCÉDÉS ASSOCIÉS
    申请人:RA PHARMACEUTICALS INC
    公开号:WO2020205501A1
    公开(公告)日:2020-10-08
    The present disclosure presents compounds and compositions that interact with complement components. Some compounds inhibit complement activity. Included are small molecule compounds and compositions that function as C5 inhibitor compounds. Methods for inhibiting complement activity and methods of treating complement-related indications with the C5 inhibitor compounds and compositions are provided.
    本公开涉及与补体成分相互作用的化合物和组合物。一些化合物抑制补体活性。包括作为C5抑制剂化合物的小分子化合物和组合物。提供了抑制补体活性的方法以及利用C5抑制剂化合物和组合物治疗与补体相关症状的方法。
  • [EN] ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS<br/>[FR] UTILISATION D'ACIDES PHENYLACETIQUES SUBSTITUES PAR ALPHA-(ARYLOXY, ARYLAMINO, ARYLTHIO OU ARYLMETHYLE SUBSTITUE PAR TRIFLUOROMETHYLE)-TRIFLUOROMETHYLE ET DE LEURS DERIVES EN TANT QU'AGENTS ANTIDIABETIQUES
    申请人:METABOLEX INC
    公开号:WO2005080340A1
    公开(公告)日:2005-09-01
    Compounds having a formula (1) or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.
    提供具有公式(1)或其药物可接受的盐或前药的化合物,可用于治疗代谢紊乱。
  • [EN] INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS DE TYROSINE KINASE DE BRUTON ET LEURS PROCÉDÉS D'UTILISATION
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2018103058A1
    公开(公告)日:2018-06-14
    Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').
    公式(I')的化合物及其使用和制备方法,以及包含公式(I')化合物的组合物。
  • Cycloalkanecarboxanilide derivative herbicides
    申请人:Shell Oil Company
    公开号:US04166735A1
    公开(公告)日:1979-09-04
    Certain cycloalkanecarboxanilide derivatives are useful as herbicides.
    某些环烷基甲酸苯胺生物作为除草剂是有用的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫